{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:11:55Z","timestamp":1780337515307,"version":"3.54.1"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Background<\/jats:title>\n Progressive familial intrahepatic cholestasis (PFIC) refers to a group of inherited cholestatic liver diseases that affect children, often leading to liver failure and requiring liver transplantation (LT). Many studies have established correlations between the effect of the causal gene variant types and the severity of the PFIC phenotype, the treatment considered, or its outcomes in patients. Nevertheless, no selection criteria for LT based on genotypes have been adopted for patients affected by this group of diseases. Therefore, we conducted a meta-analysis to investigate the association between the main PFIC subtype genotypes and the treatment with LT.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Online databases were searched for articles on PFIC1\u20134 and LT. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. The genotypes of patients were extracted from the included studies and categorized into a group of cases, harboring null genotypes, and a group of controls, harboring non-null genotypes. The relationship between the genotype type and LT outcome was expressed as an OR by assessing the LT event among the case group and the control group.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Eighteen studies involving 420 PFIC patients were included. A random-effects model was used to assess the OR. Overall, we observed a close relationship between the PFIC null genotype and the LT event; OR=2.79 (95% CI:1.63 to 4.77; p\u2009<\u20090.001). Subgroup analysis according to the PFIC subtype showed the same effect.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Our results provide evidence of a potential association between null genotypes in PFIC diseases and the indication of LT as a treatment. Further trials are needed to confirm our results and guide decisions regarding personalized and early preventive LT.<\/jats:p>\n <\/jats:sec>\n \n Research protocol registration<\/jats:title>\n \n https:\/\/doi.org\/10.17605\/OSF.IO\/MNQWB<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0350508","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:50:13Z","timestamp":1780336213000},"page":"e0350508","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Types of genotypes in progressive familial intrahepatic cholestasis and liver transplantation: A meta-analysis of observational studies"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2289-3551","authenticated-orcid":true,"given":"Rania","family":"Sakka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hela","family":"Abroug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrine Ben","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mongi","family":"Mekki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridha","family":"M\u2019rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"47","key":"pone.0350508.ref001","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.3748\/wjg.v26.i47.7470","article-title":"Molecular overview of progressive familial intrahepatic cholestasis","volume":"26","author":"S Amirneni","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"5","key":"pone.0350508.ref002","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3748\/wjg.v23.i5.763","article-title":"Current and future therapies for inherited cholestatic liver diseases","volume":"23","author":"WL van der Woerd","year":"2017","journal-title":"World J Gastroenterol"},{"key":"pone.0350508.ref003","volume-title":"Progressive familial intrahepatic cholestasis","author":"A Siddiqi","year":"2024"},{"issue":"2","key":"pone.0350508.ref004","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5500\/wjt.v6.i2.278","article-title":"Liver transplantation and the management of progressive familial intrahepatic cholestasis in children","volume":"6","author":"A Mehl","year":"2016","journal-title":"World J Transplant"},{"issue":"5","key":"pone.0350508.ref005","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/hep.23539","article-title":"ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history","volume":"51","author":"A Davit-Spraul","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"pone.0350508.ref006","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.95.1.282","article-title":"Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis","volume":"95","author":"JM de Vree","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"pone.0350508.ref007","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","article-title":"The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood","volume":"120","author":"E Jacquemin","year":"2001","journal-title":"Gastroenterology"},{"issue":"2","key":"pone.0350508.ref008","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.31787","article-title":"Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency","volume":"74","author":"DBE van Wessel","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"pone.0350508.ref009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2020.02.007","article-title":"Genotype correlates with the natural history of severe bile salt export pump deficiency","volume":"73","author":"DBE van Wessel","year":"2020","journal-title":"J Hepatol"},{"issue":"2","key":"pone.0350508.ref010","doi-asserted-by":"crossref","first-page":"100626","DOI":"10.1016\/j.jhepr.2022.100626","article-title":"Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency","volume":"5","author":"A Felzen","year":"2022","journal-title":"JHEP Rep"},{"issue":"3","key":"pone.0350508.ref011","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11901-020-00527-9","article-title":"Selection for Liver Transplantation: Indications and Evaluation","volume":"19","author":"N Mahmud","year":"2020","journal-title":"Curr Hepatol Rep"},{"issue":"7","key":"pone.0350508.ref012","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"PRISMA Group","year":"2009","journal-title":"PLoS Med"},{"issue":"5","key":"pone.0350508.ref013","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"S Richards","year":"2015","journal-title":"Genet Med"},{"issue":"3","key":"pone.0350508.ref014","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ymgme.2014.07.006","article-title":"Liver transcript analysis reveals aberrant splicing due to silent and intronic variations in the ABCB11 gene","volume":"113","author":"A Davit-Spraul","year":"2014","journal-title":"Mol Genet Metab"},{"key":"pone.0350508.ref015","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/ijms22020784","article-title":"The Bile Salt Export Pump: Molecular Structure, Study Models and Small-Molecule Drugs for the Treatment of Inherited BSEP Deficiencies","volume":"22","author":"MI Sohail","year":"2021","journal-title":"Int J Mol Sci"},{"key":"pone.0350508.ref016","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2019"},{"key":"pone.0350508.ref017","unstructured":"Harrer M, Cuijpers P, Furukawa TA, Ebert DD. Doing Meta-Analysis in R. https:\/\/bookdown.org\/MathiasHarrer\/Doing_Meta_Analysis_in_R\/citing-this-guide-1.html"},{"key":"pone.0350508.ref018","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2024"},{"key":"pone.0350508.ref019","doi-asserted-by":"crossref","DOI":"10.1002\/0470870168","author":"HR Rothstein","year":"2005","journal-title":"Publication bias in meta\u2010analysis: Prevention, assessment and adjustments"},{"issue":"4","key":"pone.0350508.ref020","article-title":"Native liver survival in bile salt export pump deficiency: results of a retrospective cohort study","volume":"7","author":"E-D Pfister","year":"2023","journal-title":"Hepatol Commun"},{"issue":"6","key":"pone.0350508.ref021","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1053\/jhep.2000.20520","article-title":"A missense mutation in FIC1 is associated with greenland familial cholestasis","volume":"32","author":"LW Klomp","year":"2000","journal-title":"Hepatology"},{"issue":"2","key":"pone.0350508.ref022","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep.21287","article-title":"Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency","volume":"44","author":"AS Knisely","year":"2006","journal-title":"Hepatology"},{"key":"pone.0350508.ref023","doi-asserted-by":"crossref","unstructured":"Strautnieks SS, Byrne JA, Pawlikowska L, Cebecauerov\u00e1 D, Rayner A, Dutton L, et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology. 2008. pp. 1203\u201314. https:\/\/doi.org\/10.1053\/j.gastro.2008.01.038","DOI":"10.1053\/j.gastro.2008.01.038"},{"issue":"5","key":"pone.0350508.ref024","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/PAS.0b013e318212ec87","article-title":"Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studies","volume":"35","author":"K Evason","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"pone.0350508.ref025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MPG.0b013e3181f50363","article-title":"Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations","volume":"52","author":"C Colombo","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"pone.0350508.ref026","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng.2918","article-title":"Mutations in TJP2 cause progressive cholestatic liver disease","volume":"46","author":"M Sambrotta","year":"2014","journal-title":"Nat Genet"},{"issue":"12","key":"pone.0350508.ref027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145021","article-title":"Genetics and Molecular Modeling of New Mutations of Familial Intrahepatic Cholestasis in a Single Italian Center","volume":"10","author":"I Giovannoni","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"pone.0350508.ref028","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/hep4.1149","article-title":"Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset","volume":"2","author":"SB Schatz","year":"2018","journal-title":"Hepatol Commun"},{"issue":"6","key":"pone.0350508.ref029","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5223\/pghn.2020.23.6.558","article-title":"Phenotypic and Molecular Characteristics of Children with Progressive Familial Intrahepatic Cholestasis in South China","volume":"23","author":"W Zhang","year":"2020","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"pone.0350508.ref030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fped.2020.00414","article-title":"Targeted Next-Generation Sequencing in Diagnostic Approach to Monogenic Cholestatic Liver Disorders-Single-Center Experience","volume":"8","author":"P Lipi\u0144ski","year":"2020","journal-title":"Front Pediatr"},{"issue":"11","key":"pone.0350508.ref031","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3390\/genes12111837","article-title":"The Genetics of Inherited Cholestatic Disorders in Neonates and Infants: Evolving Challenges","volume":"12","author":"R Jeyaraj","year":"2021","journal-title":"Genes (Basel)"},{"key":"pone.0350508.ref032","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2021.04.040","article-title":"ATP8B1, ABCB11, and ABCB4 Genes Defects: Novel Mutations Associated with Cholestasis with Different Phenotypes and Outcomes","volume":"236","author":"A Al-Hussaini","year":"2021","journal-title":"J Pediatr"},{"key":"pone.0350508.ref033","doi-asserted-by":"crossref","first-page":"100342","DOI":"10.1016\/j.aohep.2021.100342","article-title":"Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up","volume":"25","author":"P Lipi\u0144ski","year":"2021","journal-title":"Ann Hepatol"},{"issue":"1","key":"pone.0350508.ref034","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s13023-022-02597-y","article-title":"Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures","volume":"17","author":"R Chen","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"pone.0350508.ref035","doi-asserted-by":"crossref","first-page":"1074229","DOI":"10.3389\/fsurg.2023.1074229","article-title":"Progressive familial intrahepatic cholestasis-outcome and time to transplant after biliary diversion according to genetic subtypes","volume":"10","author":"A Sahloul","year":"2023","journal-title":"Front Surg"},{"issue":"1","key":"pone.0350508.ref036","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1067\/mpd.2002.119993","article-title":"FIC1 and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low gamma-glutamyltranspeptidase levels","volume":"140","author":"H-L Chen","year":"2002","journal-title":"J Pediatr"},{"issue":"4","key":"pone.0350508.ref037","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4132\/jptm.2019.05.03","article-title":"Progressive Familial Intrahepatic Cholestasis in Korea: A Clinicopathological Study of Five Patients","volume":"53","author":"HJ Kang","year":"2019","journal-title":"J Pathol Transl Med"},{"key":"pone.0350508.ref038","doi-asserted-by":"crossref","first-page":"100342","DOI":"10.1016\/j.aohep.2021.100342","article-title":"Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up","volume":"25","author":"P Lipi\u0144ski","year":"2021","journal-title":"Ann Hepatol"},{"key":"pone.0350508.ref039","unstructured":"National Heart, Lung, and Blood Institute. Study Quality Assessment Tools. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools 2014."},{"issue":"2","key":"pone.0350508.ref040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MPG.0000000000003153","article-title":"Mutation Analysis and Disease Features at Presentation in a Multi-Center Cohort of Children With Monogenic Cholestasis","volume":"73","author":"PM Hertel","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"pone.0350508.ref041","first-page":"000537","article-title":"A New Mutation Causing Progressive Familiar Intrahepatic Cholestasis Type 3 in Association with Autoimmune Hepatitis","volume":"4","author":"HM Oliveira","year":"2017","journal-title":"Eur J Case Rep Intern Med"},{"key":"pone.0350508.ref042","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/pediatric16010011","article-title":"Pediatric Autoimmune Hepatitis","volume":"16","author":"S Nastasio","year":"2024","journal-title":"Pediatric Reports"},{"issue":"7","key":"pone.0350508.ref043","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2174\/138955709788452676","article-title":"Diagnosis and therapy of autoimmune hepatitis","volume":"9","author":"A Granito","year":"2009","journal-title":"Mini Rev Med Chem"},{"issue":"10","key":"pone.0350508.ref044","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000286","article-title":"Management and outcomes after liver transplantation for progressive familial intrahepatic cholestasis: A systematic review and meta-analysis","volume":"7","author":"AM Kavallar","year":"2023","journal-title":"Hepatol Commun"},{"issue":"1","key":"pone.0350508.ref045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clinre.2018.07.010","article-title":"Systematic review of progressive familial intrahepatic cholestasis","volume":"43","author":"A Baker","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"pone.0350508.ref046","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00367.2007","article-title":"Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells","volume":"294","author":"T Kagawa","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"pone.0350508.ref047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-4-1","article-title":"Progressive familial intrahepatic cholestasis","volume":"4","author":"A Davit-Spraul","year":"2009","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"pone.0350508.ref048","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng.2918","article-title":"Mutations in TJP2 cause progressive cholestatic liver disease","volume":"46","author":"M Sambrotta","year":"2014","journal-title":"Nat Genet"},{"key":"pone.0350508.ref049","article-title":"Progressive familial intrahepatic cholestasis","author":"E Jacquemin","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"pone.0350508.ref050","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/humu.23947","article-title":"TJP2 hepatobiliary disorders: Novel variants and clinical diversity","volume":"41","author":"J Zhang","year":"2020","journal-title":"Hum Mutat"},{"issue":"10","key":"pone.0350508.ref051","doi-asserted-by":"crossref","first-page":"100844","DOI":"10.1016\/j.jhepr.2023.100844","article-title":"Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy","volume":"5","author":"E Gonzales","year":"2023","journal-title":"JHEP Rep"},{"issue":"3","key":"pone.0350508.ref052","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/14728214.2024.2336986","article-title":"Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials","volume":"29","author":"WFJ Hof","year":"2024","journal-title":"Expert Opin Emerg Drugs"},{"issue":"24","key":"pone.0350508.ref053","doi-asserted-by":"crossref","first-page":"7508","DOI":"10.3390\/jcm13247508","article-title":"Practical Considerations for Odevixibat Treatment in Patients with Progressive Familial Intrahepatic Cholestasis: A Single-Center Case Series","volume":"13","author":"M Marx","year":"2024","journal-title":"J Clin Med"},{"issue":"7","key":"pone.0350508.ref054","doi-asserted-by":"crossref","first-page":"104245","DOI":"10.1016\/j.ejmg.2021.104245","article-title":"Defining the natural history of rare genetic liver diseases: Lessons learned from the NAPPED initiative","volume":"64","author":"DBE van Wessel","year":"2021","journal-title":"Eur J Med Genet"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:50:28Z","timestamp":1780336228000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350508"}},"subtitle":[],"editor":[{"given":"Alessandro","family":"Granito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350508","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}